This suggests that ITGAL may play a role in regulating immune cell infiltration, affecting the organism’s tumor microenvironment and immune response, and may play a moderately important role in immune escape, leading to tumor immune alterations that result in a poor prognosis for patients with NSCLC. This evidence concerns the gene ITGAL and neoplasm.